Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glimepiride Initiation Monotherapy in Chinese T2DM
NCT00908921Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2009
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Apr 2009; status: completed.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00908921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00908921.